7Bone B,Aspelin P,Bronge L,et al. Contrast enhanced MRI imaging as a prognostic indicator of breast cancer [ J ] , Acta Radiol, 1998,39 ( 3 ) : 279 - 284.
8Fournier LS, Novikov V, Lucidi V. MR monitoring of cyclooxygenase- 2 inhibition of angiogenesis in a human breast cancer model in rats [J]. Radiology, 2007, 243 : 105 - 111.
9Gajdos C, Tartter PI, Bleiweiss IJ, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics[ J ]. Ann Surg, 2002,235 : 246 - 251.
6Sandoval-Hermosillo F, V~tzquez-Lara GA, et al. Comparing two diagnostic methods used for breast neoplasm in a cancer centre in Colima, Mexico [ J ]. Rev Salud Publica (Bogota), 2010,12 ( 3 ): 446 - 453.
7Abdul|ah N, Mesurolle B, E1-Khoury M, et al. Breast imaging reporting and data system lexicon for US:interobserver agreement for assessment of breast masses [ J ]. Radiology, 2009,252 ( 3 ) : 665 - 672.
8Kuroki-Suzuki S, Kuroki Y, Ishikawa T, et al. Diagnosis of breast cancer with multidetector computed tomography: analysis of optimal delay time after contrast media injection [ J ]. Clin Imaging,2010,34( 1 ) :14 - 19.
9Wasuthit Y, Kongdan Y, Suvikapakornkul R, et al. Predictive factors of axillary lymph node metastasis in breast cancer [ J ]. J Med Assoc Thai ,2011,94( 1 ) :65 -70.
10Kinsella JM, Jimenez RE, Karmali PP, et al. X - Ray computed tomography imaging of breast cancer by using targeted peptide-la- beled bismuth sulfide nanoparticles[ J]. Angew Chem Int Ed Engl, 2011,50(51) :12308 - 12311.
